There is quite a few points in this. Yes they have a path to market for the eye RP drug. This will be needed to fund the company. The other stuff re iMyc will take a long time and also the concept of injecting a tumour is unrealistic imo as, for example, if you inject say an apple with dye, how do you get dye into all of the flesh. ?That would be nigh impossible. Cancer will recurr if you remove 99% of it. So i doubt that is the way forward. The concept that we treat blood borne cancers first i think is where they got to, there are plenty of those leukaemia and mybe lymphomas to work on.
But lets crack the eye first and stay focussed.
PYC Price at posting:
6.2¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)